22nd Biennial International Conference on HTLV

June 3, 2026 through June 6, 2026

12:00 AM-12:00 AM

About: The primary focus of this meeting is on the cancer and neuroinflammation caused by Human T lymphotropic virus, which is a close cousin of Human Immunodeficiency virus (HIV) but with the ability to transform T cells and cause leukaemia. Visit the HTLV Conference 2026 website to learn more.

Register Here

Abstract Submission Deadline: Monday, December 15, 2025

The HTLV Conference 2026 invites research papers of high quality in areas of HTLV research. Abstract submissions are peer reviewed for quality of research, scientific content, and logical presentation. Accepted abstracts are scheduled as oral or poster abstract presentations. Learn more.

Contact Information

Pooja Jain, MS, BEd, PhD
pj27@drexel.edu